APA (7th ed.) Citation

Elorbany, S., Berlato, C., Carnevalli, L. S., Maniati, E., Barry, S. T., Wang, J., . . . Balkwill, F. (2024). Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer. Nature Communications, 15, . https://doi.org/10.1038/s41467-024-54295-x

Chicago Style (17th ed.) Citation

Elorbany, Samar, Chiara Berlato, Larissa S. Carnevalli, Eleni Maniati, Simon T. Barry, Jun Wang, Ranjit Manchanda, Julia Kzhyshkowska, and Frances Balkwill. "Immunotherapy That Improves Response to Chemotherapy in High-grade Serous Ovarian Cancer." Nature Communications 15 (2024). https://doi.org/10.1038/s41467-024-54295-x.

MLA (9th ed.) Citation

Elorbany, Samar, et al. "Immunotherapy That Improves Response to Chemotherapy in High-grade Serous Ovarian Cancer." Nature Communications, vol. 15, 2024, https://doi.org/10.1038/s41467-024-54295-x.